Figures 4 and 5 reveals a highly consistent pattern: medium and high AAPR values that can serve as an independent favorable prognostic indicator in advanced NSCLC were observed across nearly all the subgroups except for patients with number of treatment lines >3 or a positive status for ALK rearrangement (both P value >.05). The gene discussed is ALK; the disease is non-small cell lung carcinoma.